Bromometric Estimation of Cefixime, Clarithromy cin and Clindamycin in Bulk and Dosage Forms | ||||
Zagazig Journal of Pharmaceutical Sciences | ||||
Article 7, Volume 22, Issue 2, December 2013, Page 58-68 PDF (2.55 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/zjps.2013.163454 | ||||
View on SCiNiTO | ||||
Authors | ||||
Sobhy EI-Adl ; Mohamed ELHossinny; Marwa Hassan | ||||
Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. | ||||
Abstract | ||||
Two spectrophotometric methods are described for determination of Clarithromycin, Clindamycin and Cefixime in bulk and pharmaceutical dosage forms using insitu generated bromine as oxidizing agent and either methylene blue or methyl orange as chromogenic agents. Drugs are treated with known excess of bromine and residual unreacted bromine is determined by treating with fixed amount of either methylene blue or methyl orange then measuring absorbances at (666nm for clindamycin and cefixime or678 nm for clanthromycin) and 510 nm respectively, The amount of bromine reacted corresponds to the amount of each drug.The effect's of acidity, bromate-bromide volume and time, on the absorption were studied. Calibration curves were linear over ranges of 3.2 -16 µg.ml-1 for Clanithromycin, 1.6- 4.8 ug.ml-1 for Clindamycin, 0.8-7.2 ug.ml-1 for Cefixime in case of methylene blue and of 6.4–19.2 µg.ml-1 for Clarithromycin, 0.8-4.0µg.ml-1 for Clindamycin, 0.4-2 µg.ml-1 for Cefixime in case of methyl orange. The methods were satisfactory applied for the determination of drugs in both bulk and pharmaceutical dosage forms and results were compared statistically with reference methods. | ||||
Statistics Article View: 109 PDF Download: 77 |
||||